ITMCTR2000003062招募中1 期
Exploratory Study on the Safety and Effectiveness of Yizhi Qingxin Decoction (Capsules) in the Treatment of Hypertension in the Elderly With Mild Cognitive Impairment (Deficiency of Kidney Essence Syndrome)
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 65 至 75（—）
- 性别
- All
入选标准
- •(1) Meet the diagnostic criteria for elderly hypertension.
- •(2) Meet the MCI diagnostic criteria.
- •(3) Comply with the dialectical standard of kidney essence deficiency deficiency of traditional Chinese medicine.
- •(4) Aged 65-75 years;
- •(5) Adequate vision and hearing department to undergo neuropsychological tests;
- •(6) Have a certain level of education and can read and write simple sentences;
- •(7) Sign the informed consent
排除标准
- •(1) Dementia of various causes, including AD, VaD, or other types of dementia, that have met the DSM-IV diagnostic criteria for dementia, such as Parkinson's disease, Huntington's disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, chronic hard sub-membrane hematoma and multiple sclerosis, with a history of severe head trauma with persistent neurological deficits or known brain structural abnormalities;
- •(2) Sleep disorders that may affect cognitive performance, drug or alcohol abuse or dependence in the previous 5 years, and other can interfere with factors that affect cognitive performance such as depression (HAMD> 12 points) or mental disorders;
- •(3) CT or MRI scans in the past 12 months show central nervous system infection, infarction, and other focal damage;
- •Heikinski Ischemic Scale (HIS)> 4 points;
- •(4) Other conditions that should not be participated in this study, such as hypertension emergency, hypertension crisis, and drug taking controlled hypertension, severe arrhythmia, or cardiac function grade 3-4, or myocardial infarction occurred within 3 months before participating in the trial, etc .;
- •(5) Chinese medicine, anticholinergic, anticonvulsant, antiparkinsonian, excitatory, cholinergic, antipsychotic, or anticholinergic or cholinergic antidepressant or anxiolytic of patients, known to be allergic to this medicine;
- •(6) Severe liver and kidney dysfunction, such as ALT or AST above 1.5 times the normal value, or the upper limit of serum Cr normal value;
- •(7) Severe asthma and chronic obstructive pulmonary disease;
- •(8) Patients with severe indigestion, gastrointestinal obstruction, gastric or duodenal ulcers;
- •(9) Those who are participating in other clinical trials;
- •(10) Subjects that the investigator believes cannot follow the study procedure.
研究者
相似试验
招募中
2 期
Research on the effectiveness and safety of microwave mammographybreast cancerJPRN-jRCTs052180188Yamagami Kazuhiko400
进行中（未招募）
1 期
EXPLORATORY STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CD07387 SOLUTION IN PATIENTS WITH VITILIGOEUCTR2010-019994-13-FRGALDERMA R&D36
已完成
3 期
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsMedication Refractory Essential TremorJPRN-UMIN000033752Medical Corporation Tokushukai Shonanfujisawa Tokushukai Hospital10
已完成
不适用
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsEssential TremorJPRN-UMIN000023639Departments of Neurology and Neurosurgery, Hokuto Hospital10
已完成
3 期
A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor SubjectsMedication Refractory Essential TremorJPRN-UMIN000019498Department of Neurosurgery, Osaka University School of Medicine10